Kwality Pharmaceuticals Limited
KPL (NSE) · KPL (BSE 539997) · ISIN INE552U01010 · Pharmaceuticals · Est. 1983 · listed 2026 · website
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹333.37 cr | ₹130.46 cr | ₹595.66 cr |
| 30 Sep 2025 standalone | ₹291.92 cr | ₹110.44 cr | ₹481.11 cr |
| 31 Mar 2025 standalone | ₹265.84 cr | ₹112.45 cr | ₹450.72 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 54.86% | 2.50% | 1.07% | 45.14% |
Latest filings
- SCRUTINIZER REPORT OF AGM E-VOTING IS ATTACHED 2 September 2026 · BSE
- Proceedings of 43rd Annual General Meeting attached herewith. 31 August 2026 · BSE
- Transcript of Earnings Conference Call - Q1FY27 12 August 2026 · BSE
- Transcript of Earnings Conference Call - Q1FY27 12 August 2026 · BSE
- Investor Presentation for quarter ended June 30, 2026. 10 August 2026 · BSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.